Prognosis and epidemiology of amyotrophic lateral sclerosis: Analysis of a clinic population, 1997-2011
- PMID: 24195020
- PMCID: PMC3787117
- DOI: 10.1212/CPJ.0b013e3182a1b8ab
Prognosis and epidemiology of amyotrophic lateral sclerosis: Analysis of a clinic population, 1997-2011
Abstract
Amyotrophic lateral sclerosis is a disease with highly variable clinical features and prognosis. We analyzed the prognostic indicators of age, sex, bulbar or spinal onset, body mass index (BMI), and forced vital capacity (FVC) for 728 deceased patients from the Emory ALS Clinic. The median overall survival was 29.8 months from symptom onset, 15.8 months from diagnosis, and 14.3 months from the initial clinic visit. While univariate analyses revealed that each of the identified clinical features was strongly associated with patient survival, in multivariable analyses only age, BMI, and FVC measured at the first clinic visit were independent prognostic indicators; bulbar onset and sex were not significantly associated with survival prognosis after adjustment for the other clinical features.
References
-
- Chancellor AM, Slattery JM, Fraser H, Swingler RJ, Holloway SM, Warlow CP. The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register. J Neurol 1993;240:339–346 - PubMed
-
- Chio A, Calvo A, Moglia C, Mazzini L, Mora G. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 2011;82:740–746 - PubMed
-
- Chio A, Mutani R, Mora G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 2003;61:1826–1827; author reply 1827 - PubMed
-
- Czaplinski A, Yen AA, Appel SH. Amyotrophic lateral sclerosis: early predictors of prolonged survival. J Neurol 2006;253:1428–1436 - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous